Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
280.00
+12.40 (4.63%)
Apr 14, 2026, 5:29 PM CET

Xvivo Perfusion AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8,8205,87815,40310,3795,4598,215
Market Cap Growth
-26.51%-61.84%48.41%90.12%-33.55%-8.90%
Enterprise Value
8,6525,72214,9789,8105,1507,936
Last Close Price
280.00186.60489.00329.50183.00278.50
PE Ratio
350.51233.5989.46113.04296.261007.78
Forward PE
73.1151.1992.61199.34111.93211.39
PS Ratio
10.867.2418.7317.3713.1531.80
PB Ratio
4.172.787.145.343.826.39
P/TBV Ratio
6.034.0110.817.846.8610.06
P/FCF Ratio
1200.80800.25379.773172.09564.50-
P/OCF Ratio
87.2758.16138.41224.23195.98-
EV/Sales Ratio
10.657.0518.2116.4212.4030.71
EV/EBITDA Ratio
61.2344.25126.47515.41387.15-
EV/EBIT Ratio
91.6460.61164.891818.081156.32-
EV/FCF Ratio
1178.01779.09369.292998.27532.54-
Debt / Equity Ratio
0.060.060.020.020.010.00
Debt / EBITDA Ratio
0.880.880.261.060.51-
Debt / FCF Ratio
16.9816.980.849.611.03-
Net Debt / Equity Ratio
-0.08-0.08-0.18-0.26-0.16-0.31
Net Debt / EBITDA Ratio
-1.29-1.29-3.22-27.04-17.7833.59
Net Debt / FCF Ratio
-22.79-22.79-9.41-157.29-24.4617.66
Asset Turnover
0.340.340.360.300.250.19
Inventory Turnover
0.890.891.121.231.291.02
Quick Ratio
3.443.443.144.942.604.43
Current Ratio
5.775.774.586.153.475.24
Return on Equity (ROE)
1.18%1.18%8.39%5.44%1.36%0.71%
Return on Assets (ROA)
2.47%2.47%2.47%0.17%0.17%-0.87%
Return on Invested Capital (ROIC)
3.17%3.31%4.88%0.40%0.35%-2.41%
Return on Capital Employed (ROCE)
4.20%4.20%4.10%0.30%0.30%-1.30%
Earnings Yield
0.29%0.43%1.12%0.89%0.34%0.10%
FCF Yield
0.08%0.13%0.26%0.03%0.18%-0.27%
Buyback Yield / Dilution
0.29%0.29%-5.73%-1.39%-2.04%-6.49%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.